-
1
-
-
70449851433
-
Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
-
European Society of Hypertension
-
Mancia G, Laurent S, Agabiti-Rosei E, et al; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-58.
-
(2009)
J Hypertens
, vol.27
, pp. 2121-2158
-
-
Mancia, G.1
Laurent, S.2
Agabiti-Rosei, E.3
-
2
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
-
National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee
-
Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
-
(2003)
JAMA
, vol.289
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
3
-
-
72049116836
-
Use of diuretics in patients with hypertension
-
Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009; 361: 2153-64.
-
(2009)
N Engl J Med
, vol.361
, pp. 2153-2164
-
-
Ernst, M.E.1
Moser, M.2
-
4
-
-
58149457772
-
All thiazide-like diuretics are not chlorthalidone: Putting the ACCOMPLISH study into perspective
-
Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich) 2009; 11: 5-10.
-
(2009)
J Clin Hypertens (Greenwich)
, vol.11
, pp. 5-10
-
-
Ernst, M.E.1
Carter, B.L.2
Basile, J.N.3
-
5
-
-
79953243999
-
Evidencebased diuretic therapy for improving cardiovascular prognosis in systemic hypertension
-
Al Badarin FJ, Abuannadi MA, Lavie CJ, O'Keefe JH. Evidencebased diuretic therapy for improving cardiovascular prognosis in systemic hypertension. Am J Cardiol 2011; 107: 1178-84.
-
(2011)
Am J Cardiol
, vol.107
, pp. 1178-1184
-
-
Al Badarin, F.J.1
Abuannadi, M.A.2
Lavie, C.J.3
O'Keefe, J.H.4
-
6
-
-
77949653924
-
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium
-
Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens 2010; 23: 440-6.
-
(2010)
Am J Hypertens
, vol.23
, pp. 440-446
-
-
Ernst, M.E.1
Carter, B.L.2
Zheng, S.3
Grimm Jr., R.H.4
-
7
-
-
79953219740
-
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: A retrospective cohort analysis
-
Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011; 57: 689-94.
-
(2011)
Hypertension
, vol.57
, pp. 689-694
-
-
Dorsch, M.P.1
Gillespie, B.W.2
Erickson, S.R.3
Bleske, B.E.4
Weder, A.B.5
-
8
-
-
0346102472
-
Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability
-
Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004; 43: 4-9.
-
(2004)
Hypertension
, vol.43
, pp. 4-9
-
-
Carter, B.L.1
Ernst, M.E.2
Cohen, J.D.3
-
9
-
-
27744579877
-
Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
-
Khosla N, Chua DY, Elliott WJ, Bakris GL. Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications? J Clin Hypertens (Greenwich) 2005; 7: 354-6.
-
(2005)
J Clin Hypertens (Greenwich)
, vol.7
, pp. 354-356
-
-
Khosla, N.1
Chua, D.Y.2
Elliott, W.J.3
Bakris, G.L.4
-
10
-
-
84861532412
-
Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate
-
Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension 2012; 59: 1104-9.
-
(2012)
Hypertension
, vol.59
, pp. 1104-1109
-
-
Peterzan, M.A.1
Hardy, R.2
Chaturvedi, N.3
Hughes, A.D.4
-
11
-
-
33644981542
-
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
-
Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006; 47: 352-8.
-
(2006)
Hypertension
, vol.47
, pp. 352-358
-
-
Ernst, M.E.1
Carter, B.L.2
Goerdt, C.J.3
-
12
-
-
21744446081
-
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study
-
Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46: 156-61.
-
(2005)
Hypertension
, vol.46
, pp. 156-161
-
-
Dolan, E.1
Stanton, A.2
Thijs, L.3
-
13
-
-
15744389626
-
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide
-
Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide. Am J Hypertens 2005; 18: 398-402.
-
(2005)
Am J Hypertens
, vol.18
, pp. 398-402
-
-
Finkielman, J.D.1
Schwartz, G.L.2
Chapman, A.B.3
Boerwinkle, E.4
Turner, S.T.5
-
14
-
-
79251482197
-
Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: A meta-analysis of randomized trials
-
Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol 2011; 57: 590-600.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 590-600
-
-
Messerli, F.H.1
Makani, H.2
Benjo, A.3
Romero, J.4
Alviar, C.5
Bangalore, S.6
-
15
-
-
78649365900
-
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis
-
Karagiannis A, Tziomalos K, Anagnostis P, et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol 2010; 8: 792-803.
-
(2010)
Curr Vasc Pharmacol
, vol.8
, pp. 792-803
-
-
Karagiannis, A.1
Tziomalos, K.2
Anagnostis, P.3
-
17
-
-
0019364057
-
Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: A double-blind controlled trial
-
Grimm RH Jr, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med 1981; 94: 7-11.
-
(1981)
Ann Intern Med
, vol.94
, pp. 7-11
-
-
Grimm Jr., R.H.1
Leon, A.S.2
Hunninghake, D.B.3
Lenz, K.4
Hannan, P.5
Blackburn, H.6
-
18
-
-
0033594220
-
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
-
Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1999; 159: 551-8.
-
(1999)
Arch Intern Med
, vol.159
, pp. 551-558
-
-
Lakshman, M.R.1
Reda, D.J.2
Materson, B.J.3
Cushman, W.C.4
Freis, E.D.5
-
19
-
-
9344253821
-
Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group
-
Grimm RH Jr, Flack JM, Grandits GA, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996; 275: 1549-56.
-
(1996)
JAMA
, vol.275
, pp. 1549-1556
-
-
Grimm Jr., R.H.1
Flack, J.M.2
Grandits, G.A.3
-
20
-
-
0027182440
-
Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss
-
Bradley K, Flack JM, Belcher J, Elmer P, Miller P, Grimm R Jr. Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss. Am J Hypertens 1993; 6: 636-9.
-
(1993)
Am J Hypertens
, vol.6
, pp. 636-639
-
-
Bradley, K.1
Flack, J.M.2
Belcher, J.3
Elmer, P.4
Miller, P.5
Grimm Jr., R.6
-
21
-
-
84870826740
-
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
-
Christogiannis LG, Kostapanos MS, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension. J Hum Hypertens 2013; 27: 44-50.
-
(2013)
J Hum Hypertens
, vol.27
, pp. 44-50
-
-
Christogiannis, L.G.1
Kostapanos, M.S.2
Tellis, C.C.3
Milionis, H.J.4
Tselepis, A.D.5
Elisaf, M.S.6
-
22
-
-
0032513534
-
Influence of long-term, lowdose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group
-
Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, lowdose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998; 158: 741-51.
-
(1998)
Arch Intern Med
, vol.158
, pp. 741-751
-
-
Savage, P.J.1
Pressel, S.L.2
Curb, J.D.3
-
23
-
-
0030730635
-
An effective approach for treating elderly patients with isolated systolic hypertension: Results of an Italian multicenter study with fosinopril
-
Leonetti G, Trimarco B, Collatina S, Tosetti A. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. Am J Hypertens 1997; 10: 230S-235S.
-
(1997)
Am J Hypertens
, vol.10
-
-
Leonetti, G.1
Trimarco, B.2
Collatina, S.3
Tosetti, A.4
-
24
-
-
84857039982
-
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol
-
Smith SM, Gong Y, Turner ST, et al. Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol. Am J Hypertens 2012; 25: 359-65.
-
(2012)
Am J Hypertens
, vol.25
, pp. 359-365
-
-
Smith, S.M.1
Gong, Y.2
Turner, S.T.3
-
25
-
-
84942005552
-
Is thiazideproduced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program
-
Langford HG, Blaufox MD, Borhani NO, et al. Is thiazideproduced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987; 147: 645-9.
-
(1987)
Arch Intern Med
, vol.147
, pp. 645-649
-
-
Langford, H.G.1
Blaufox, M.D.2
Borhani, N.O.3
-
26
-
-
13644253783
-
The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial
-
Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991; 90: 50S-54S.
-
(1991)
Am J Med
, vol.90
-
-
Staessen, J.1
-
27
-
-
84861225023
-
Use of diuretics and the risk of gouty arthritis: A systematic review
-
Hueskes BA, Roovers EA, Mantel-Teeuwisse AK, Janssens HJ, van de Lisdonk EH, Janssen M. Use of diuretics and the risk of gouty arthritis: a systematic review. Semin Arthritis Rheum 2012; 41: 879-89.
-
(2012)
Semin Arthritis Rheum
, vol.41
, pp. 879-889
-
-
Hueskes, B.A.1
Roovers, E.A.2
Mantel-Teeuwisse, A.K.3
Janssens, H.J.4
van de Lisdonk, E.H.5
Janssen, M.6
-
28
-
-
33846023704
-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
-
Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant 2007; 22: 118-27.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 118-127
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Liberopoulos, E.N.3
-
29
-
-
34347230840
-
Serum uric acid as an independent predictor of early death after acute stroke
-
Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007; 71: 1120-7.
-
(2007)
Circ J
, vol.71
, pp. 1120-1127
-
-
Karagiannis, A.1
Mikhailidis, D.P.2
Tziomalos, K.3
-
31
-
-
0033851739
-
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)
-
Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18: 1149-54.
-
(2000)
J Hypertens
, vol.18
, pp. 1149-1154
-
-
Franse, L.V.1
Pahor, M.2
Di Bari, M.3
-
32
-
-
0028321729
-
Diuretic therapy for hypertension and the risk of primary cardiac arrest
-
Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-7.
-
(1994)
N Engl J Med
, vol.330
, pp. 1852-1857
-
-
Siscovick, D.S.1
Raghunathan, T.E.2
Psaty, B.M.3
-
33
-
-
80052874960
-
The meaning of hypokalemia in heart failure
-
Bielecka-Dabrowa A, Mikhailidis DP, Jones L, Rysz J, Aronow WS, Banach M. The meaning of hypokalemia in heart failure. Int J Cardiol 2012; 158: 12-7.
-
(2012)
Int J Cardiol
, vol.158
, pp. 12-17
-
-
Bielecka-Dabrowa, A.1
Mikhailidis, D.P.2
Jones, L.3
Rysz, J.4
Aronow, W.S.5
Banach, M.6
-
34
-
-
0034034398
-
Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program
-
Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025-30.
-
(2000)
Hypertension
, vol.35
, pp. 1025-1030
-
-
Franse, L.V.1
Pahor, M.2
Di Bari, M.3
Somes, G.W.4
Cushman, W.C.5
Applegate, W.B.6
-
35
-
-
0026531151
-
Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men
-
Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 1992; 267: 1083-9.
-
(1992)
JAMA
, vol.267
, pp. 1083-1089
-
-
Siegel, D.1
Hulley, S.B.2
Black, D.M.3
-
36
-
-
36849022128
-
Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
-
Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007; 28: 2937-43.
-
(2007)
Eur Heart J
, vol.28
, pp. 2937-2943
-
-
Conen, D.1
Ridker, P.M.2
Mora, S.3
Buring, J.E.4
Glynn, R.J.5
-
37
-
-
0034732256
-
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study
-
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342: 905-12.
-
(2000)
N Engl J Med
, vol.342
, pp. 905-912
-
-
Gress, T.W.1
Nieto, F.J.2
Shahar, E.3
Wofford, M.R.4
Brancati, F.L.5
-
38
-
-
33846294746
-
Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis
-
Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 201-7.
-
(2007)
Lancet
, vol.369
, pp. 201-207
-
-
Elliott, W.J.1
Meyer, P.M.2
-
39
-
-
0020672404
-
Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium
-
Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983; 32: 106-11.
-
(1983)
Diabetes
, vol.32
, pp. 106-111
-
-
Helderman, J.H.1
Elahi, D.2
Andersen, D.K.3
-
40
-
-
33748147006
-
Thiazide diuretics, potassium, and the development of diabetes: A quantitative review
-
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 219-24.
-
(2006)
Hypertension
, vol.48
, pp. 219-224
-
-
Zillich, A.J.1
Garg, J.2
Basu, S.3
Bakris, G.L.4
Carter, B.L.5
-
41
-
-
33748139496
-
Thiazide-associated glucose abnormalities: Prognosis, etiology, and prevention: Is potassium balance the key?
-
Cutler JA. Thiazide-associated glucose abnormalities: prognosis, etiology, and prevention: is potassium balance the key? Hypertension 2006; 48: 198-200.
-
(2006)
Hypertension
, vol.48
, pp. 198-200
-
-
Cutler, J.A.1
-
42
-
-
57449120453
-
Changes in serum potassium mediate thiazide-induced diabetes
-
Shafi T, Appel LJ, Miller ER 3rd, Klag MJ, Parekh RS. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 2008; 52: 1022-9.
-
(2008)
Hypertension
, vol.52
, pp. 1022-1029
-
-
Shafi, T.1
Appel, L.J.2
Miller III, E.R.3
Klag, M.J.4
Parekh, R.S.5
-
43
-
-
57449121574
-
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: The mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study
-
Eriksson JW, Jansson PA, Carlberg B, et al. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension 2008; 52: 1030-7.
-
(2008)
Hypertension
, vol.52
, pp. 1030-1037
-
-
Eriksson, J.W.1
Jansson, P.A.2
Carlberg, B.3
-
44
-
-
84857132090
-
Non-alcoholic Fatty liver disease in type 2 diabetes: Pathogenesis and treatment options
-
Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic Fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol 2012; 10: 162-72.
-
(2012)
Curr Vasc Pharmacol
, vol.10
, pp. 162-172
-
-
Tziomalos, K.1
Athyros, V.G.2
Karagiannis, A.3
-
45
-
-
77549087054
-
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
-
Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375: 735-42.
-
(2010)
Lancet
, vol.375
, pp. 735-742
-
-
Sattar, N.1
Preiss, D.2
Murray, H.M.3
-
46
-
-
84865147415
-
Pharmacotherapy: Statins and newonset diabetes mellitus-a matter for debate
-
Athyros VG, Mikhailidis DP. Pharmacotherapy: Statins and newonset diabetes mellitus-a matter for debate. Nat Rev Endocrinol 2012; 8: 133-4.
-
(2012)
Nat Rev Endocrinol
, vol.8
, pp. 133-134
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
-
48
-
-
79551640972
-
Preventing type 2 diabetes mellitus: Room for residual risk reduction after lifestyle changes?
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr Pharm Des 2010; 16: 3939-847.
-
(2010)
Curr Pharm Des
, vol.16
, pp. 3847-3939
-
-
Athyros, V.G.1
Tziomalos, K.2
Karagiannis, A.3
Mikhailidis, D.P.4
-
49
-
-
2342652390
-
Adverse prognostic significance of new diabetes in treated hypertensive subjects
-
Verdecchia P, Reboldi G, Angeli F, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-9.
-
(2004)
Hypertension
, vol.43
, pp. 963-969
-
-
Verdecchia, P.1
Reboldi, G.2
Angeli, F.3
-
50
-
-
0037471841
-
Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study
-
Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ 2003; 326: 681.
-
(2003)
BMJ
, vol.326
, pp. 681
-
-
Dunder, K.1
Lind, L.2
Zethelius, B.3
Berglund, L.4
Lithell, H.5
-
51
-
-
0032925773
-
Diabetes and cardiovascular events in hypertensive patients
-
Alderman MH, Cohen H, Madhavan S. Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130-4.
-
(1999)
Hypertension
, vol.33
, pp. 1130-1134
-
-
Alderman, M.H.1
Cohen, H.2
Madhavan, S.3
-
52
-
-
77953302606
-
Effect of antihypertensive drug-associated diabetes on cardiovascular risk
-
Karagiannis A, Tziomalos K, Pagourelias ED, Gossios TD, Athyros VG. Effect of antihypertensive drug-associated diabetes on cardiovascular risk. Hellenic J Cardiol 2010; 51: 195-9.
-
(2010)
Hellenic J Cardiol
, vol.51
, pp. 195-199
-
-
Karagiannis, A.1
Tziomalos, K.2
Pagourelias, E.D.3
Gossios, T.D.4
Athyros, V.G.5
-
53
-
-
11144228978
-
Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
-
SHEP Collaborative Research Group
-
Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR; SHEP Collaborative Research Group. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29-35.
-
(2005)
Am J Cardiol
, vol.95
, pp. 29-35
-
-
Kostis, J.B.1
Wilson, A.C.2
Freudenberger, R.S.3
Cosgrove, N.M.4
Pressel, S.L.5
Davis, B.R.6
-
54
-
-
33750999057
-
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Collaborative Research Group
-
Barzilay JI, Davis BR, Cutler JA, et al; ALLHAT Collaborative Research Group. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006; 166: 2191-201.
-
(2006)
Arch Intern Med
, vol.166
, pp. 2191-2201
-
-
Barzilay, J.I.1
Davis, B.R.2
Cutler, J.A.3
-
55
-
-
84860859230
-
Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study
-
for the ALLHAT Collaborative Research Group
-
Barzilay JI, Davis BR, Pressel SL, et al; for the ALLHAT Collaborative Research Group. Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study. Circ Cardiovasc Qual Outcomes 2012; 5: 153-162.
-
(2012)
Circ Cardiovasc Qual Outcomes
, vol.5
, pp. 153-162
-
-
Barzilay, J.I.1
Davis, B.R.2
Pressel, S.L.3
-
56
-
-
10544229794
-
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
-
Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886-92.
-
(1996)
JAMA
, vol.276
, pp. 1886-1892
-
-
Curb, J.D.1
Pressel, S.L.2
Cutler, J.A.3
-
57
-
-
22144439426
-
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Collaborative Research Group
-
Whelton PK, Barzilay J, Cushman WC, et al; ALLHAT Collaborative Research Group. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005; 165: 1401-9.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1401-1409
-
-
Whelton, P.K.1
Barzilay, J.2
Cushman, W.C.3
-
58
-
-
53049108337
-
Metabolic syndrome and incident diabetes: Current state of the evidence
-
Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 2008; 31: 1898-904.
-
(2008)
Diabetes Care
, vol.31
, pp. 1898-1904
-
-
Ford, E.S.1
Li, C.2
Sattar, N.3
-
59
-
-
77957198071
-
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis
-
Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-32.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1113-1132
-
-
Mottillo, S.1
Filion, K.B.2
Genest, J.3
-
60
-
-
38949084591
-
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
-
Black HR, Davis B, Barzilay J, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 2008; 31: 353-60.
-
(2008)
Diabetes Care
, vol.31
, pp. 353-360
-
-
Black, H.R.1
Davis, B.2
Barzilay, J.3
-
61
-
-
0018579580
-
Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group
-
Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242: 2562-71.
-
(1979)
JAMA
, vol.242
, pp. 2562-2571
-
-
-
62
-
-
0020061073
-
Five-year findings of the hypertension detection and follow-up program III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group
-
Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982; 247: 633-8.
-
(1982)
JAMA
, vol.247
, pp. 633-638
-
-
-
63
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-64.
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
64
-
-
0030744599
-
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group
-
Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997; 278: 212-6.
-
(1997)
JAMA
, vol.278
, pp. 212-216
-
-
Kostis, J.B.1
Davis, B.R.2
Cutler, J.3
-
65
-
-
84255182798
-
Association between chlorthalidone treatment of systolic hypertension and long-term survival
-
Kostis JB, Cabrera J, Cheng JQ, et al. Association between chlorthalidone treatment of systolic hypertension and long-term survival. JAMA 2011; 306: 2588-93.
-
(2011)
JAMA
, vol.306
, pp. 2588-2593
-
-
Kostis, J.B.1
Cabrera, J.2
Cheng, J.Q.3
-
66
-
-
0344373794
-
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
67
-
-
33646766401
-
Role of diuretics in the prevention of heart failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
-
Davis BR, Piller LB, Cutler JA, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006; 113: 2201-10.
-
(2006)
Circulation
, vol.113
, pp. 2201-2210
-
-
Davis, B.R.1
Piller, L.B.2
Cutler, J.A.3
-
68
-
-
0042835370
-
Diuretic versus alphablocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alphablocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-46.
-
(2003)
Hypertension
, vol.42
, pp. 239-246
-
-
-
69
-
-
0031861208
-
Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program
-
Pahor M, Shorr RI, Somes GW, et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998; 158: 1340-5.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1340-1345
-
-
Pahor, M.1
Shorr, R.I.2
Somes, G.W.3
-
70
-
-
33644855606
-
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate
-
ALLHAT Collaborative Research Group
-
Rahman M, Pressel S, Davis BR, et al; ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144: 172-80.
-
(2006)
Ann Intern Med
, vol.144
, pp. 172-180
-
-
Rahman, M.1
Pressel, S.2
Davis, B.R.3
-
71
-
-
20244371503
-
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Rahman M, Pressel S, Davis BR, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005; 165: 936-46.
-
(2005)
Arch Intern Med
, vol.165
, pp. 936-946
-
-
Rahman, M.1
Pressel, S.2
Davis, B.R.3
-
72
-
-
28844504752
-
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis
-
Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026-33.
-
(2005)
Lancet
, vol.366
, pp. 2026-2033
-
-
Casas, J.P.1
Chua, W.2
Loukogeorgakis, S.3
-
73
-
-
43749112197
-
Effects of different ACE inhibitor combinations on albuminuria: Results of the GUARD study
-
GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators
-
Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P; GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008; 73: 1303-9.
-
(2008)
Kidney Int
, vol.73
, pp. 1303-1309
-
-
Bakris, G.L.1
Toto, R.D.2
McCullough, P.A.3
Rocha, R.4
Purkayastha, D.5
Davis, P.6
-
74
-
-
0021864792
-
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
-
Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-54.
-
(1985)
Lancet
, vol.1
, pp. 1349-1354
-
-
Amery, A.1
Birkenhäger, W.2
Brixko, P.3
-
75
-
-
0026512315
-
Medical Research Council trial of treatment of hypertension in older adults: Principal results MRC Working Party
-
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405-12.
-
(1992)
BMJ
, vol.304
, pp. 405-412
-
-
-
76
-
-
0019197138
-
Treatment of mild hypertension: A five year controlled drug trial. The Oslo study
-
Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725-32.
-
(1980)
Am J Med
, vol.69
, pp. 725-732
-
-
Helgeland, A.1
-
77
-
-
0023433489
-
Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial
-
Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987; 5: 561-72.
-
(1987)
J Hypertens
, vol.5
, pp. 561-572
-
-
Wilhelmsen, L.1
Berglund, G.2
Elmfeldt, D.3
-
78
-
-
0023947123
-
Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
-
Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988; 259: 1976-82.
-
(1988)
JAMA
, vol.259
, pp. 1976-1982
-
-
Wikstrand, J.1
Warnold, I.2
Olsson, G.3
Tuomilehto, J.4
Elmfeldt, D.5
Berglund, G.6
-
79
-
-
0037434556
-
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly
-
Second Australian National Blood Pressure Study Group
-
Wing LM, Reid CM, Ryan P, et al; Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-92.
-
(2003)
N Engl J Med
, vol.348
, pp. 583-592
-
-
Wing, L.M.1
Reid, C.M.2
Ryan, P.3
-
80
-
-
0034729993
-
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
-
Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-72.
-
(2000)
Lancet
, vol.356
, pp. 366-372
-
-
Brown, M.J.1
Palmer, C.R.2
Castaigne, A.3
-
81
-
-
0037851836
-
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
-
CONVINCE Research Group
-
Black HR, Elliott WJ, Grandits G, et al; CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073-82.
-
(2003)
JAMA
, vol.289
, pp. 2073-2082
-
-
Black, H.R.1
Elliott, W.J.2
Grandits, G.3
-
82
-
-
57349138291
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
-
ACCOMPLISH Trial Investigators
-
Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-28.
-
(2008)
N Engl J Med
, vol.359
, pp. 2417-2428
-
-
Jamerson, K.1
Weber, M.A.2
Bakris, G.L.3
-
83
-
-
83155180324
-
Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial
-
Multiple Risk Factor Intervention Trial Research Group
-
Ernst ME, Neaton JD, Grimm RH Jr, et al; Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 2011; 58: 1001-7.
-
(2011)
Hypertension
, vol.58
, pp. 1001-1007
-
-
Ernst, M.E.1
Neaton, J.D.2
Grimm Jr., R.H.3
-
84
-
-
0024520312
-
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial
-
MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1989; 63: 202-10.
-
(1989)
Am J Cardiol
, vol.63
, pp. 202-210
-
-
McMahon, S.1
Collins, G.2
Rautaharju, P.3
-
85
-
-
23244450974
-
Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
-
Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J 2005; 150: 161-7.
-
(2005)
Am Heart J
, vol.150
, pp. 161-167
-
-
Hsieh, B.P.1
Pham, M.X.2
Froelicher, V.F.3
-
86
-
-
0025513896
-
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial
-
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990; 82: 1616-28.
-
(1990)
Circulation
, vol.82
, pp. 1616-1628
-
-
-
87
-
-
77955983763
-
Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis
-
Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension 2010; 56: 463-70.
-
(2010)
Hypertension
, vol.56
, pp. 463-470
-
-
Woodman, R.1
Brown, C.2
Lockette, W.3
-
88
-
-
0034520464
-
Effects of antihypertensive treatment on platelet function in essential hypertension
-
Gomi T, Ikeda T, Shibuya Y, Nagao R. Effects of antihypertensive treatment on platelet function in essential hypertension. Hypertens Res 2000; 23: 567-72.
-
(2000)
Hypertens Res
, vol.23
, pp. 567-572
-
-
Gomi, T.1
Ikeda, T.2
Shibuya, Y.3
Nagao, R.4
-
89
-
-
3042702505
-
Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based lowdose diuretic therapies
-
Psaty BM, Lumley T, Furberg CD. Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based lowdose diuretic therapies. JAMA 2004; 292: 43-4.
-
(2004)
JAMA
, vol.292
, pp. 43-44
-
-
Psaty, B.M.1
Lumley, T.2
Furberg, C.D.3
-
90
-
-
67650082354
-
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
-
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
-
(2009)
BMJ
, vol.338
-
-
Law, M.R.1
Morris, J.K.2
Wald, N.J.3
-
91
-
-
84861531899
-
Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: Systematic review and network meta-analyses
-
Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 2012; 59: 1110-7.
-
(2012)
Hypertension
, vol.59
, pp. 1110-1117
-
-
Roush, G.C.1
Holford, T.R.2
Guddati, A.K.3
-
92
-
-
0347423198
-
National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
93
-
-
70449851433
-
Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
-
European Society of Hypertension
-
Mancia G, Laurent S, Agabiti-Rosei E, et al; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-58.
-
(2009)
J Hypertens
, vol.27
, pp. 2121-2158
-
-
Mancia, G.1
Laurent, S.2
Agabiti-Rosei, E.3
-
94
-
-
84878655494
-
Hypertension
-
National Institute for Health and Clinical Excellence (NICE), [accessed 18/6/2012]
-
National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/ guidance/ CG127 [accessed 18/6/2012].
-
(2011)
The clinical management of primary hypertension in adults. Clinical Guideline
, vol.127
-
-
-
95
-
-
79958101343
-
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
-
ACCF Task Force
-
Aronow WS, Fleg JL, Pepine CJ, et al; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123: 2434-506.
-
(2011)
Circulation
, vol.123
, pp. 2434-2506
-
-
Aronow, W.S.1
Fleg, J.L.2
Pepine, C.J.3
-
96
-
-
80052379818
-
Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly
-
Banach M, Aronow WS. Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn 2011; 121: 253-8.
-
(2011)
Pol Arch Med Wewn
, vol.121
, pp. 253-258
-
-
Banach, M.1
Aronow, W.S.2
-
97
-
-
84867397911
-
Hypertension therapy in the older adultsdo we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly
-
Banach M, Aronow WS. Hypertension therapy in the older adultsdo we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens 2012; 26: 641-3.
-
(2012)
J Hum Hypertens
, vol.26
, pp. 641-643
-
-
Banach, M.1
Aronow, W.S.2
|